KKR & Co. Inc.
For the period ended Sep 30, 2025. Filed Nov 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 7, 2025
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2025-06-30; filed 2025-08-08.
0001404912-25-000032
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2025-09-30; filed 2025-11-07.
0001404912-25-000042
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 10 previous paragraphs and 12 current paragraphs.
7 unchanged; 3 reworded; 1 added; 0 removed; 0 previous and 1 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Current report
On July 30, 2025, and September 29, 2025, in connection with our acquisition of a majority ownership stake in HealthCare Royalty Management, LLC, a biopharma royalty acquisition company, we issued an aggregate of 0.4 million restricted holdings units through KKR Holdings III (“Holdings III Units”) as partial consideration for the transaction. Holdings III Units may be exchanged for shares of KKR common stock on a one-for-one basis, subject to applicable vesting and certain other conditions. The Holdings III Units were issued pursuant to Section 4(a)(2) of the Securities Act, exempting issuances by an issuer not involving a public offering.
Reworded paragraphs (3)
Previous wording
Share Repurchases in the Second Quarter of 2025
Current wording
Share Repurchases in the Three Months Ended September 30, 2025
Previous wording
As of July 25, 2025, there is approximately $459 million remaining under KKR's share repurchase program.
Current wording
As of October 31, 2025, there is approximately $440 million remaining under KKR's share repurchase program.
Previous wording
The table below sets forth the information with respect to repurchases made by or on behalf of KKR & Co. Inc. or any "affiliated purchaser" (as defined in Rule 10b-18(a)(3) under the Exchange Act) of our common stock for the periods presented. During the second quarter of 2025, 36,411 shares of common stock were repurchased, and 917,903 equity awards were retired.
Current wording
The table below sets forth the information with respect to repurchases made by or on behalf of KKR & Co. Inc. or any "affiliated purchaser" (as defined in Rule 10b-18(a)(3) under the Exchange Act) of our common stock for the periods presented. During the three months ended September 30, 2025, no shares of common stock were repurchased, and 8,333 equity awards were retired.
Rearranged current paragraphs (1)
Current report — wording carried from elsewhere
Unregistered Sales of Equity in the Three Months Ended September 30, 2025